Clinical trials
Phase 3 Leukemia, Myelomonocytic, Chronic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astex Pharmaceuticals, Inc. | 2 |
| Children's Oncology Group | 2 |
| Martin, Paul | 1 |
| NCIC Clinical Trials Group | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| SWOG Cancer Research Network | 1 |
| Takeda | 1 |
| The Canadian Blood and Marrow Transplant Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 11 |
| Myelodysplastic Syndromes | 9 |
| Myeloproliferative Disorders | 5 |
| Burkitt Lymphoma | 4 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.